Pharmaceutical Companies: Please, Stop Haggling!

Chapter 201 Acquisition of new drugs

According to the detailed introduction in the information, this anti-tuberculosis drug has already passed the second round of clinical testing at this time. It only needs to go through one round of clinical testing before it can be put on the market and undergo application review.

Once a new drug passes the review, it can be approved for marketing. This is a piece of meat that is almost cooked. Chu Feng can’t understand why the other party wants to sell this drug.

"This is a drug that is about to be approved for marketing. It can just make up for the lack of pediatric anti-tuberculosis drugs in the market. Why is this company so anxious to sell this drug?"

Chu Feng asked the question in his mind. This was the point he couldn't understand the most. If he takes this medicine now, he will lose money, at least half of his money.

Chu Feng understands that no company will be stupid enough to lose billions in vain. Although it takes a long time to recover the funds, it is a better profit in the long run.

"I have conducted a detailed investigation. Due to poor management of this company, the chairman hastily invested a large amount of money in drug research without much experience. Now the capital chain has been broken, so it was sold in a hurry."

Chu Feng nodded in panic. No one can understand better than the prescription the research and development costs required to research a drug, and the very likely result that it will be nothing.

This company is not very large, but it actually invested in the research of three new drugs at once, and the research costs of these three new drugs are very high.

Once the capital chain is broken, half of the researched drugs will not bring any value to wages. In the end, they can only reluctantly sell half of the researched drugs at low prices.

Chu Feng's eyes were full of excitement at this time. As a medical student, he could see the great value of this anti-tuberculosis drug at a glance, so he spoke directly to Master Liu Cong in front of him without any hesitation.

"Immediately make an appointment with their chairman for me. I want to talk to him about the acquisition of this drug, and promise that if there is an opportunity to cooperate, I will also consider acquiring the other two drugs."

Although Chu Feng did not know the development status of the other two drugs, he knew from the reactions of Liu Congshuai and others that there was probably little progress in the development of the other two drugs, so the condition proposed by Chu Feng was very tempting.

Liu Congshuai hesitated after hearing Chu Feng's words. He didn't understand what Chu Feng wanted to do with the other two drugs that had no value.

However, Liu Congshuai did not have any doubts about Chu Feng. He nodded and contacted the other party's chairman with the information.

Half an hour later, Liu Congshuai came to Chu Feng happily, handed a piece of paper to Chu Feng, and said to Chu Feng with a smile.

"I have made an appointment with the chairman opposite. At 6:30 tonight, he will be waiting for you in the private room No. 666 of Jinsheng Hotel!"

Chu Feng nodded slowly, took the note, and entered the number on it into the address book of his mobile phone. He did not rush to call the other party's chairman, but began to search for information about tuberculosis drugs on the Internet. information.

According to the current market situation, anti-tuberculosis drugs do have a large market. Currently, the mainstream drugs on the market are generally divided into bactericidal and bacteriostatic drugs.

…Please give me flowers…

The two drugs have different working principles and different therapeutic effects on tuberculosis. However, according to the current market situation, first-line anti-tuberculosis drugs such as rifampicin and ethanol are

All have major side effects.

On the other hand, the anti-tuberculosis drug Chu Feng is about to acquire has much fewer side effects than the mainstream first-line anti-tuberculosis drugs currently on the market, and it is especially effective in anti-tuberculosis treatment for children.

Chu Feng spent a whole afternoon searching for information in the office, and the time soon came to six o'clock. In order to avoid being late due to traffic jams, Chu Feng drove to the Jinsheng Hotel early and arrived ten minutes early. We arrived at Box 666.

....0

At this time, the other party's chairman had been waiting in the box early. After seeing Chu Feng, he greeted Chu Feng warmly and then asked Chu Feng to take a seat.

"Mr. Chu, I have heard of your name a long time ago. I didn't expect that you would be interested in our drug, so I will no longer hide it. "Presumably Mr. Chu already has some knowledge about our drug. Got a certain understanding!”

Chu Feng nodded slowly and took out some detailed evaluations about the medicine that he had investigated.

"I have a general understanding of the research and development process of your drug, and I am very interested in this business, so I am here to talk to you about the acquisition. I hope they can be more sincere!"

After Chu Feng sat down, the food in the hotel was gradually served. The other party stood up and poured a glass of red wine for Chu Feng and said with a smile.

"As long as the price is right, we can sign the contract today!"